Thursday, February 12, 2026 | 03:06 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sanket Koul

Sanket Koul

Sanket Koul

Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.

Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.

Email

Page 27 - Sanket Koul

2 suspected GBS cases from Delhi NCR region admitted in Jaipur

Sources indicated the patients are admitted in Jaipur's Sawai Man Singh Hospital

2 suspected GBS cases from Delhi NCR region admitted in Jaipur
Updated On : 05 Feb 2025 | 11:19 PM IST

Changing ties: USAID funding to India on the decline since pandemic

Experts feel that funding freeze may not move the needle much; but some projects will be in limbo

Changing ties: USAID funding to India on the decline since pandemic
Updated On : 04 Feb 2025 | 11:39 PM IST

Medanta Hospitals Q3 results: PAT rises 15.6% on higher patient volumes

Company board approves signing of lease agreement for a new 110-bed hospital in Ranchi

Medanta Hospitals Q3 results: PAT rises 15.6% on higher patient volumes
Updated On : 04 Feb 2025 | 8:30 PM IST

Metropolis Healthcare, Roche team up to launch HPV DNA testing in India

"The HPV test will be rolled out on February 4 to coincide with World Cancer Day," an official with Metropolis said

Metropolis Healthcare, Roche team up to launch HPV DNA testing in India
Updated On : 03 Feb 2025 | 8:19 PM IST

Alembic Pharma Q3 results: PAT falls 23.29% amid market headwinds

Alembic's revenue from operations rose to Rs 1,692.74 crore in Q3FY25, a 3.8 per cent Y-o-Y increase from Rs 1,630.57 crore in Q3FY24

Alembic Pharma Q3 results: PAT falls 23.29% amid market headwinds
Updated On : 03 Feb 2025 | 8:11 PM IST

Union Budget 2025-26: PMJAY allocation may not suffice, say experts

Budget estimates (BE) for the financial year (FY) 2025-26 have put the allocation for PMJAY at Rs 9,406 crore, a 28.8 per cent increase from Rs 7,300 crore in FY25's BE

Union Budget 2025-26: PMJAY allocation may not suffice, say experts
Updated On : 03 Feb 2025 | 12:00 AM IST

Union Budget 2025: 10k new medical seats in 2025, 6500 new seats in 5 IITs

Govt to set up 50,000 more Atal Tinkering Labs in govt schools, excellence centre for AI in education

Union Budget 2025: 10k new medical seats in 2025, 6500 new seats in 5 IITs
Updated On : 01 Feb 2025 | 12:49 PM IST

OOPE declines, school enrolments rise as social expenditure surges: Survey

Economic survey says India could attain WHO doctor availability norms of 1:1000 by 2030

OOPE declines, school enrolments rise as social expenditure surges: Survey
Updated On : 01 Feb 2025 | 12:22 AM IST

Pharmaceutical companies, CDSCO to discuss regulatory matters on Friday

It is expected that representatives for MSMEs pharma manufacturers may raise the issue of extension of Revised Schedule M implementation timelines

Pharmaceutical companies, CDSCO to discuss regulatory matters on Friday
Updated On : 31 Jan 2025 | 12:47 AM IST

NE states lag behind even as India improves girls' toilet facilities

This comes even as the country has increased girls' toilet coverage in rural schools from 66.4 per cent in 2018 to 72 per cent in 2024

NE states lag behind even as India improves girls' toilet facilities
Updated On : 31 Jan 2025 | 12:37 AM IST

Max Healthcare Q3 results: PAT drops 17.4% to Rs 289 cr, revenue up 40%

Hospital chain to set up 500 bed hospital in Thane on built-to-suit basis, focus on brownfield expansion

Max Healthcare Q3 results: PAT drops 17.4% to Rs 289 cr, revenue up 40%
Updated On : 30 Jan 2025 | 11:02 PM IST

Haryana govt likely to sanction Rs 230 crore to part pay PMJAY dues

Haryana IMA calls it inadequate as unpaid dues since October amount to Rs 400 cr

Haryana govt likely to sanction Rs 230 crore to part pay PMJAY dues
Updated On : 28 Jan 2025 | 9:59 PM IST

DLF sells 41% units of super luxury Dahlias project in nine weeks

Buyers now more involved in ultra-luxury housing, says DLF Home Developers Joint MD

DLF sells 41% units of super luxury Dahlias project in nine weeks
Updated On : 27 Jan 2025 | 10:36 PM IST

FIITJEE blames managing partners for closure of centres as police files FIR

Sources says institute is working on recruiting new staff, trying to open back soon

FIITJEE blames managing partners for closure of centres as police files FIR
Updated On : 25 Jan 2025 | 9:13 PM IST

DLF Q3FY25 results: Consolidated net profit rises 61% to Rs 1,058.73 cr

DLF's revenue from operations grew marginally by 0.5 per cent to Rs 1,528.7 crore in Q3FY25, compared to Rs 1,521.2 crore in Q3FY24

DLF Q3FY25 results: Consolidated net profit rises 61% to Rs 1,058.73 cr
Updated On : 24 Jan 2025 | 10:58 PM IST

Doctors may face suspension in NMC probe over pharma-sponsored trips

This was in violation of the UCPMP rules, which regulate interactions between pharmaceutical companies and HCPs and prohibit foreign trips, gifts, and inducements as unethical marketing practices

Doctors may face suspension in NMC probe over pharma-sponsored trips
Updated On : 24 Jan 2025 | 7:22 PM IST

CDSCO flags 135 drugs for failing quality standards for December 2024

Most drugs found NSQ by central labs this month were produced in units located in cities such as Ahmedabad, Vadodara, Himachal Pradesh's Baddi, Puducherry, Roorkee and Haridwar

CDSCO flags 135 drugs for failing quality standards for December 2024
Updated On : 24 Jan 2025 | 6:21 PM IST

Mankind Pharma Q3FY25 results: PAT falls 16.5%, revenue rises 24%

Mankind's revenue from operations rose to Rs 3,230 crore in Q3FY25, a 24 per cent Y-o-Y rise from Rs 2,607 crore reported in Q3FY24

Mankind Pharma Q3FY25 results: PAT falls 16.5%, revenue rises 24%
Updated On : 23 Jan 2025 | 10:30 PM IST

Dr Reddy's Labs Q3 results: PAT rises 2.5% at Rs 1,413 cr, revenue up 16%

The growth was largely driven by revenue from its recently acquired nicotine replacement therapy (NRT) portfolio and performance in the European and emerging markets

Dr Reddy's Labs Q3 results: PAT rises 2.5% at Rs 1,413 cr, revenue up 16%
Updated On : 23 Jan 2025 | 8:39 PM IST

Union cabinet extends National Health Mission for another 5 years

Govt says India on track to meet SDG health targets well before 2030 deadline

Union cabinet extends National Health Mission for another 5 years
Updated On : 22 Jan 2025 | 11:34 PM IST